Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SUV39H2 | Q9H5I1 | 2/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.46 |
| ▸ | NR1H2 | P55055 | 11/20 | 0.44 |
| ▸ | NR1H3 | Q13133 | 11/20 | 0.44 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4573063 | 1.00 | SUV39H2 (0.48) | SUV39H2MAP4K4NR1H2NR1H3GPR119 | |
| SCHEMBL4573668 | 0.90 | SUV39H2 (0.50) | SUV39H2MAP4K4NR1H2NR1H3GPR119 | |
| SCHEMBL4573141 | 0.90 | SUV39H2 (0.50) | SUV39H2MAP4K4NR1H2NR1H3GPR119 | |
| SCHEMBL4573448 | 0.89 | SUV39H2 (0.48) | SUV39H2MAP4K4NR1H2NR1H3GPR119 | |
| SCHEMBL4574549 | 0.87 | SUV39H2 (0.40) | SUV39H2FAAHCCR1 | |
| SCHEMBL21659668 | 0.85 | GPR119 (0.49) | SUV39H2MAP4K4NR1H2NR1H3GPR119 | |
| SCHEMBL21659242 | 0.85 | GPR119 (0.49) | SUV39H2MAP4K4NR1H2NR1H3GPR119 | |
| SCHEMBL28520938 | 0.85 | GPR119 (0.49) | SUV39H2MAP4K4NR1H2NR1H3GPR119 | |
| SCHEMBL8116063 | 0.85 | GPR119 (0.51) | SUV39H2MAP4K4NR1H2NR1H3GPR119 | |
| SCHEMBL4573114 | 0.85 | GPR119 (0.51) | SUV39H2MAP4K4NR1H2NR1H3GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009001127-A1 | CYANOCYCLOPROPYLCARBOXAMIDES AS CATHEPSIN INHIBITORS | ASTRAZENECA AB (SE) | 2008-12-31 | — | — | WO | disclosed |